Hong Kong Dermatology Drugs Market Analysis

Hong Kong Dermatology Drugs Market Analysis


$ 3999

By 2030, it is anticipated that the Hong Kong Dermatology drugs market will reach a value of $xx Mn from $27.24 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as ASLAN Pharmaceuticals, LEO Pharma, and Bright Future Pharmaceutical Laboratories Ltd. The market is driven by slow research and development, OTC, and government regulations. The dermatology drug market in Hong Kong is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.

ID: IN10HKPH008 CATEGORY: Pharmaceuticals GEOGRAPHY: Hong Kong AUTHOR: Dr. Vishwa Modhia

Buy Now

Hong Kong Dermatology Drugs Market Analysis Summary

By 2030, it is anticipated that the Hong Kong Dermatology drugs market will reach a value of $xx Mn from $27.24 Mn in 2022, growing at a CAGR of xx% during 2022-2030.

Hong Kong is home to a developed public healthcare system with significant healthcare spending. The World Bank reports that in 2020, Hong Kong's Gross Domestic Product (GDP) as a percentage of total health spending was 5.6%.

This shows that Hong Kong is committed to offering its citizens high-quality healthcare services because it is relatively high in comparison to other nations in the region. Retail pharmacists concentrate primarily on over-the-counter (OTC) medications in a physician-dispensing market like Hong Kong.

Market Dynamics

Market Growth Drivers

Hong Kong is a great starting point for foreign businesses looking to expand into Asia and the greater Indo-Pacific because of its sizable market, proximity to mainland China and Southeast Asia, and recognition of FDA approvals for medical and pharmaceutical products.

In a physician-dispensing market such as Hong Kong, retail pharmacists primarily focus on over-the-counter (OTC) drugs. The consumption of dermatology medications will be impacted by these trends.

Market Restraints

The dermatology drug market's potential size may be constrained by Hong Kong's relatively small population. This can discourage new players from entering the market.

Competitive Landscape

Key Players

  • Bright Future Pharmaceutical Laboratories Ltd (HKG)
  • LEO Pharma (HKG)
  • ASLAN Pharmaceuticals (HKG)
  • Takeda Pharmaceutical Company (HKG)
  • Menarini (HKG)
  • GlaxoSmithKline
  • Pfizer
  • Sanofi
  • Johnson & Johnson

Healthcare Regulations and Reimbursement Policies

The regulatory body responsible for overseeing the dermatology drug market in Hong Kong is the Department of Health (DH). All medicines, including dermatology medications, must be registered with and approved by the DH before they can be used in Hong Kong. To safeguard the public's health, the DH works to ensure the efficacy, quality, and safety of every drug sold on the market. It also regulates how these drugs are distributed and used.

In Hong Kong, there is a mix of public and private funding for dermatology drugs and treatments. A wide range of medical services, including dermatology care and medication, are covered by the public healthcare system known as the Hospital Authority.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Dermatology Drugs Market Segmentation

The Dermatology Drugs Market is segmented as mentioned below

By Disease (Revenue, USD Billion):

  • Psoriasis
  • Acne Vulgaris
  • Atopic Dermatitis
  • Eczema
  • Rosacea
  • Itchthyosis
  • Vitiligo
  • Others

By Route Of Administration (Revenue, USD Billion):

  • Oral
  • Parenteral
  • Topical

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others  

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 07 February 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up